trial

Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

NCTId NCT07152184
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Not Yet Recruiting
Enrollment 288 (estimated)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2032-02-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Not Yet Recruiting
Enrollment
288 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2026-10-01
Primary completion
2032-02-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
—

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Sites

0 total

Linked catalysts

1
Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patien — primary completion2032-02-01

Facts & assertions

4 sourced
Enrollment
288
Phase
PHASE2
Primary Completion Date
2032-02-01
Status
NOT_YET_RECRUITING
relationships
The graph out of here
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Patient With Schizophrenia Spectrum Disorder
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication